IXICO plc Stock price

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. 12:35:09 2024-03-28 pm EDT 5-day change 1st Jan Change
8.1 GBX -6.36% Intraday chart for IXICO plc -1.82% -35.20%
Sales 2024 * 5.2M 6.56M Sales 2025 * - Capitalization 3.92M 4.95M
Net income 2024 * -2M -2.53M Net income 2025 * - EV / Sales 2024 * 0.48 x
Net cash position 2024 * 1.4M 1.77M Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-1.47 x
P/E ratio 2025 *
-
Employees 89
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.5%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.36%
1 week-1.82%
Current month-6.09%
1 month-7.43%
3 months-37.69%
6 months-58.25%
Current year-35.20%
More quotes
1 week
8.00
Extreme 8
8.65
1 month
6.35
Extreme 6.35
8.75
Current year
6.35
Extreme 6.35
13.50
1 year
6.35
Extreme 6.35
24.00
3 years
6.35
Extreme 6.35
105.00
5 years
6.35
Extreme 6.35
127.00
10 years
6.35
Extreme 6.35
127.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 17-02-05
Director of Finance/CFO 47 19-05-30
Chairman 59 13-10-13
Members of the board TitleAgeSince
Chairman 59 13-10-13
Director/Board Member 48 16-09-15
Director/Board Member 60 23-10-04
More insiders
Date Price Change Volume
24-03-28 8.1 -6.36% 46,877
24-03-27 8.65 +4.85% 26,793
24-03-26 8.25 +1.54% 1,014,646
24-03-25 8.125 -1.52% 131,652
24-03-22 8.25 0.00% 2,000

Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT

More quotes
IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. It offers a range of clinical trial imaging analysis tools, including radiological reads, structural and advanced magnetic resonance imaging (MRI). Its specialist data analytics services identify and measure biomarkers from brain scans and wearable biosensors.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock IXICO plc - London S.E.